See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2022_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 268,930,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 17,260,000 |
| 2 | PropertyPlantAndEquipmentNet | 668,000 |
| 3 | remainder_Assets | 15,193,000 |
| 4 | LiabilitiesCurrent | 45,347,000 |
| 5 | LiabilitiesNoncurrent | 10,960,000 |
| 6 | remainder_Liabilities | 70,136,000 |
| 7 | CostOfGoodsAndServicesSold | 1,356,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 204,413,649 |
| 9 | ResearchAndDevelopmentExpense | 88,524,986 |
| 10 | remainder_Expenses | -14,615,055 |
| 11 | remainder_Revenues | 20,828,795 |
| 12 | remainder_NetIncome | -11,037,554 |
| 13 | remainder_ComprehensiveNetIncome | -15,030,473 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 302,051,000 |
| 1 | Liabilities | 126,443,000 |
| 2 | Expenses | 279,679,580 |
| 3 | Revenues | 20,828,795 |
| 4 | StockholdersEquity | 175,608,000 |
| 5 | NetIncome | -269,888,339 |
| 6 | ComprehensiveNetIncome | -277,403,576 |
| 7 | BaseVar | 377,535,201 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.492 |
| 9 | EconomicCapitalRatio | 1.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
